Novo Nordisk Patient Assistance Program (PAP): Available Products
Statistical Analysis SPSS version 24 was used for descriptive analyses and statistical comparisons between groups
Your dose of TOUJEO may need to change because of: a change in level of physical activity or exercise, weight gain or loss, increased stress, illness, change in diet, or because of other medicines you take
A proof-of-concept, open-label trial of weekly exenatide (2 mg, 48 weeks, 50 patients) showed an advantage in the unified multiple system atrophy rating scale (UMSARS, parts I and II combined score) at 48 weeks compared with best medically treated participants, but no difference in more objective secondary measures or biomarkers (neurofilament light chain [NfL], CSF -synuclein oligomers) (165)
Give your cognitive powers a boost and increase your attention span and focus
Non-invasive beta-cell imaging: Visualization, quantification, and beyond